Related references
Note: Only part of the references are listed.X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience
Justine Bacchetta et al.
JOINT BONE SPINE (2021)
Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting
Justine Bacchetta et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Assessment of mineral and bone biomarkers highlights a high frequency of hypercalciuria in asymptomatic healthy teenagers
Justine Bacchetta et al.
ACTA PAEDIATRICA (2019)
Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report
Aurelia Berthlet-Thomas et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR
Marco van Londen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper
Khosrow Adeli et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
Paul E. Stevens et al.
ANNALS OF INTERNAL MEDICINE (2013)
Adaptation of an enzymatic polyfructosan assay to clinical practice
Laurence Dubourg et al.
ANALYTICAL BIOCHEMISTRY (2010)
Performance of iohexol determination in serum and urine by HPLC: Validation, risk and uncertainty assessment
Etienne Cavalier et al.
CLINICA CHIMICA ACTA (2008)
Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults
Massimo Cirillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram
JH Barth et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2000)